← Browse by Condition
Medical Condition
thymoma
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for thymoma sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
NCT05214612
Recruiting
Predictors and Prognostic Factors of Myasthenia Gravis Outcome
Enrollment
30 pts
Location
Egypt
Sponsor
Assiut University
NCT02633553
Recruiting
Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection
Enrollment
238 pts
Location
China
Sponsor
Fudan University
NCT06029621
Recruiting
Robot-assisted vs VATS for Thymoma
Enrollment
304 pts
Location
China
Sponsor
Shanghai Pulmonary Hospital, S...
NCT06838910 Phase 2
Recruiting
Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma
Enrollment
20 pts
Location
China
Sponsor
The First Affiliated Hospital ...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology